What is cancer polyethylene glycosylated recombinant human megakaryocyte growth and development factor?

ctSearch Results

Original Query

What is cancer polyethylene glycosylated recombinant human megakaryocyte growth and development factor?

Search Results

1. cancer polyethylene

Preview

• Polyethylene glycosylated recombinant human megakaryocyte growth and development factor is being studied as a way to increase the number of platelets in patients receiving chemotherapy


• Also called polyethylene glycosylated recombinant human megakaryocyte growth and development factor and PEG-rhMGDF


• Polyethylene glycol (PEG)-conjugated recombinant human megakaryocyte growth and development factor (MGDF, also known as PEG-rHuMGDF), a recombinant molecule related to thrombopoietin, specifically stimulates megakaryopoiesis and platelet


2. recombinant human megakaryocyte development factor

Preview

• - Thrombopoietin (TPO): recombinant human megakaryocyte growth and development factor (rhuMGDF), recombinant human thrombopoietin (rhuTPO) Monoclonal antibodies Differentiating agents-tretinoin, bexarotene Tyrosine kinase inhibitors (TKIs) TNF-


• pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating


• Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts


3. recombinant human megakaryocyte growth

Preview

• 1016/S0140-6736(96)04471-6 Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer Original TextDr MB , PhD , MB , PhD , MB , MB , RN , PhD , BSc , PhD , PhD , PhD Summary Background Pegylated recombinant human megakaryocyte


• Polyethylene glycol (PEG)-conjugated recombinant human megakaryocyte growth and development factor (MGDF, also known as PEG-rHuMGDF), a recombinant molecule related to thrombopoietin, specifically stimulates megakaryopoiesis and platelet production and reduces the severity of thrombocytopenia


• Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor

---

For more information on each topic click the link(s) above.
You may also be interested in downloading ctMedBrowser for a unique viewing experience.

---

Contact

Web : http://c-t-search.info
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo

[Return to Medical Expert][Return to Cancer Expert]